Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PD-L1 in non-small-cell lung cancer: the third target for immunotherapy.

× No keyword cloud information.

5 in total

1. Endoplasmic Reticulum Stress Causes Liver Cancer Cells to Release Exosomal miR-23a-3p and Up-regulate Programmed Death Ligand 1 Expression in Macrophages.

Authors: Jiatao Liu; Lulu Fan; Hanqing Yu; Ju Zhang; Yong He; Dechun Feng; Fang Wang; Xiaoqiu Li; Qingqing Liu; Yuhuan Li; Zhenli Guo; Bin Gao; Wei Wei; Hua Wang; Guoping Sun
Journal: Hepatology Date: 2019-04-25 Impact factor: 17.425

2. Microbial HSP70 peptide epitope 407-426 as adjuvant in tumor-derived autophagosome vaccine therapy of mouse lung cancer.

Authors: Jian Li; Yun Xing; Zhenxian Zhou; Wenjun Yao; Rongyue Cao; Taiming Li; Maolei Xu; Jie Wu
Journal: Tumour Biol Date: 2016-09-23

3. Overexpression of HN1L promotes cell malignant proliferation in non-small cell lung cancer.

Authors: Lei Li; Ting-Ting Zeng; Bao-Zhu Zhang; Yan Li; Ying-Hui Zhu; Xin-Yuan Guan
Journal: Cancer Biol Ther Date: 2017-10-20 Impact factor: 4.742

4. [Blocking programmed death-ligand 1 attenuates maturation inhibition of dendritic cells by co-cultured breast cancer cells].

Authors: Xiao-Ran Yu; Qiao-Sheng Wen; Yi Xiao; Rui Tang; Fu-Xi Li; Wen-Feng Shao; Yan-Lin Yu; Jing-Bo Xiong
Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2018-05-20

5. PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer.

Authors: Zi-Qi Zhou; Jing-Jing Zhao; Qiu-Zhong Pan; Chang-Long Chen; Yuan Liu; Yan Tang; Qian Zhu; De-Sheng Weng; Jian-Chuan Xia
Journal: J Immunother Cancer Date: 2019-08-27 Impact factor: 13.751

5 in total